We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

IVD Regulation and the Upcoming Changes in Regulatory Landscape

Track:
A New Era for Medical Devices and Diagnostics. How Is The Impact?

Day & Time:
April 18, 10:30AM - 12:00PM (Central Europe Standard Time)

Session Number:
S0701

Room Number:
Boston 3

Type:
Session

Title:
IVD Regulation and the Upcoming Changes in Regulatory Landscape

Chair(s):
Claudia Dollins, PhD, RAC
Head, Global Regulatory Affairs, Biomarkers & Diagnostics
Merck KGaA, Germany

Description:
IVD Regulation and the Upcoming Changes in Regulatory Landscape

Presentation(s) & Speaker(s):
Panel Discussion
Anna Hallersten, MSc
Head Regulatory Policy Europe
Roche Diagnostics, Switzerland

Panel Discussion
Sue Spencer
Head of Global Medical Devices
UL, United Kingdom

Panel Discussion
Stephen Lee
Senior Regulatory Policy Manager
Medicines & Healthcare Products Regulatory Agency (MHRA), United Kingdom